on
November 10, 2026
The vaccine limbo in the US is worsening the measles outbreak
Earlier doses for children, a focus on unvaccinated adults, a risk strategy based on geography – here’s how a functioning ACIP would address the measles outbreakThe US has announced three deaths associated with measles last week, among them a…
on
November 10, 2026
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
The risk appears small and data is mixed, but FDA wants patients to be aware.
on
November 10, 2026
Pharma firms’ focus on weight-loss drugs could put insulin supply at risk, experts warn
GLP-1 products such as Ozempic and Mounjaro spread but many in poorer countries struggle to get basic diabetes treatmentThe gold rush into GLP-1 weight-loss drugs risks diverting pharmaceutical firms’ attention away from diabetes treatments such as…
on
November 10, 2026
The AI Safety Debate Has Lost the Plot. We Asked 10 Experts What the Real Nightmares Are
The risk of nuclear catastrophe is real, as is the fallout of the China–US domination game (hi there, spies). But no need to panic about Skynet.